BLACKROCK CORE BOND TRUST (BHK)

US09249E1010

10.46  +0.02 (+0.19%)

Fundamental Rating

2

BHK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. BHK may be in some trouble as it scores bad on both profitability and health. BHK does not seem to be growing, but still is valued expensively.



2

1. Profitability

1.1 Basic Checks

BHK had positive earnings in the past year.
BHK had a positive operating cash flow in the past year.
BHK had positive earnings in 4 of the past 5 years.
BHK had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

The last Return On Invested Capital (2.68%) for BHK is above the 3 year average (2.64%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.87%
ROE 9.29%
ROIC 2.68%
ROA(3y)-4.45%
ROA(5y)1.39%
ROE(3y)-8.26%
ROE(5y)0.56%
ROIC(3y)2.64%
ROIC(5y)2.58%

1.3 Margins

In the last couple of years the Profit Margin of BHK has declined.
BHK's Operating Margin has declined in the last couple of years.
BHK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 58.61%
PM (TTM) 106.22%
GM 59.6%
OM growth 3Y-11.07%
OM growth 5Y-4.99%
PM growth 3Y-22.32%
PM growth 5YN/A
GM growth 3Y-11.09%
GM growth 5Y-4.95%

2

2. Health

2.1 Basic Checks

BHK has about the same amout of shares outstanding than it did 1 year ago.
BHK has more shares outstanding than it did 5 years ago.
BHK has a better debt/assets ratio than last year.

2.2 Solvency

BHK has an Altman-Z score of 0.52. This is a bad value and indicates that BHK is not financially healthy and even has some risk of bankruptcy.
BHK has a debt to FCF ratio of 2.23. This is a good value and a sign of high solvency as BHK would need 2.23 years to pay back of all of its debts.
BHK has a Debt/Equity ratio of 0.51. This is a neutral value indicating BHK is somewhat dependend on debt financing.
Although BHK does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 2.23
Altman-Z 0.52
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

BHK has a Current Ratio of 0.05. This is a bad value and indicates that BHK is not financially healthy enough and could expect problems in meeting its short term obligations.
BHK has a Quick Ratio of 0.05. This is a bad value and indicates that BHK is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05

3

3. Growth

3.1 Past

BHK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 127.20%, which is quite impressive.
Measured over the past years, BHK shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.34% on average per year.
The Revenue has grown by 8.95% in the past year. This is quite good.
Measured over the past years, BHK shows a small growth in Revenue. The Revenue has been growing by 0.26% on average per year.
EPS 1Y (TTM)127.2%
EPS 3Y-19.34%
EPS 5YN/A
EPS growth Q2Q201.15%
Revenue 1Y (TTM)8.95%
Revenue growth 3Y3.89%
Revenue growth 5Y0.26%
Revenue growth Q2Q5.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.25, which indicates a very decent valuation of BHK.
Compared to an average S&P500 Price/Earnings ratio of 27.73, BHK is valued rather cheaply.
Industry RankSector Rank
PE 10.25
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF 4.18
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.86%, BHK is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.41, BHK pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.86%

5.2 History

The dividend of BHK has a limited annual growth rate of 2.78%.
BHK has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BHK decreased recently.
Dividend Growth(5Y)2.78%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

87.49% of the earnings are spent on dividend by BHK. This is not a sustainable payout ratio.
DP87.49%
EPS Next 2YN/A
EPS Next 3YN/A

BLACKROCK CORE BOND TRUST

NYSE:BHK (5/6/2024, 10:54:01 AM)

10.46

+0.02 (+0.19%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap564.94M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 7.86%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 10.25
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.87%
ROE 9.29%
ROCE
ROIC
ROICexc
ROICexgc
OM 58.61%
PM (TTM) 106.22%
GM 59.6%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)127.2%
EPS 3Y-19.34%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)8.95%
Revenue growth 3Y3.89%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y